New agents for controlling emesis with cancer chemotherapy.

Richard J. Gralla, R. A. Clark

Research output: Contribution to journalArticle

Abstract

Over the past decade, marked progress in support techniques has been made in patients with cancer. In addition to improvement in pain and infection control, the ability to control chemotherapy-induced nausea and vomiting has improved greatly. Studies have demonstrated that serotonin type 3 receptors play an important role in mediating this side-effect. Several new agents, with excellent efficacy and few side effects have now been developed and are available clinically. Results of trials with these agents, and with newer investigative approaches are discussed.

Original languageEnglish (US)
Pages (from-to)169-173
Number of pages5
JournalThe Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
Volume145
Issue number4
StatePublished - Apr 1993
Externally publishedYes

Fingerprint

Receptors, Serotonin, 5-HT3
Aptitude
Infection Control
Nausea
Vomiting
Drug Therapy
Pain
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

New agents for controlling emesis with cancer chemotherapy. / Gralla, Richard J.; Clark, R. A.

In: The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, Vol. 145, No. 4, 04.1993, p. 169-173.

Research output: Contribution to journalArticle

@article{73ef903ca57d4d12a20e51b075a4455b,
title = "New agents for controlling emesis with cancer chemotherapy.",
abstract = "Over the past decade, marked progress in support techniques has been made in patients with cancer. In addition to improvement in pain and infection control, the ability to control chemotherapy-induced nausea and vomiting has improved greatly. Studies have demonstrated that serotonin type 3 receptors play an important role in mediating this side-effect. Several new agents, with excellent efficacy and few side effects have now been developed and are available clinically. Results of trials with these agents, and with newer investigative approaches are discussed.",
author = "Gralla, {Richard J.} and Clark, {R. A.}",
year = "1993",
month = "4",
language = "English (US)",
volume = "145",
pages = "169--173",
journal = "The New Orleans medical and surgical journal",
issn = "0024-6921",
publisher = "Louisiana State Medical society",
number = "4",

}

TY - JOUR

T1 - New agents for controlling emesis with cancer chemotherapy.

AU - Gralla, Richard J.

AU - Clark, R. A.

PY - 1993/4

Y1 - 1993/4

N2 - Over the past decade, marked progress in support techniques has been made in patients with cancer. In addition to improvement in pain and infection control, the ability to control chemotherapy-induced nausea and vomiting has improved greatly. Studies have demonstrated that serotonin type 3 receptors play an important role in mediating this side-effect. Several new agents, with excellent efficacy and few side effects have now been developed and are available clinically. Results of trials with these agents, and with newer investigative approaches are discussed.

AB - Over the past decade, marked progress in support techniques has been made in patients with cancer. In addition to improvement in pain and infection control, the ability to control chemotherapy-induced nausea and vomiting has improved greatly. Studies have demonstrated that serotonin type 3 receptors play an important role in mediating this side-effect. Several new agents, with excellent efficacy and few side effects have now been developed and are available clinically. Results of trials with these agents, and with newer investigative approaches are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0027582235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027582235&partnerID=8YFLogxK

M3 - Article

C2 - 8486990

AN - SCOPUS:0027582235

VL - 145

SP - 169

EP - 173

JO - The New Orleans medical and surgical journal

JF - The New Orleans medical and surgical journal

SN - 0024-6921

IS - 4

ER -